COVID-19 Virtual Care
- Funded by University of Minnesota
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
University of MinnesotaPrincipal Investigator
MD. Pita AdamResearch Location
United States of AmericaLead Research Institution
Medical School, University of Minnesota, University of MinnesotaResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
Digital Health
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Due to the extremely limited supply of testing kits and the highly infectious nature of COVID-19, medical providers are virtually diagnosing the virus through symptoms. M Health Fairview has implemented a virtual platform - GetWell Loop - to remotely monitor patients diagnosed with presumptive COVID-19. Patients enrolled in GetWell Loop receive daily electronic surveys asking them to report their symptoms and their temperature. Healthcare providers are alerted if patients report concerning symptoms and call the patients to assess their situation and determine next steps, such as continued monitoring or referral for evaluation. Providers will have simultaneous access to the patients' electronic health record where they can document their patients' management plan. Led by Pita Adam, MD, MSPH, associate professor of Family Medicine and Community Health, researchers will use the GetWell Loop Database to: define the natural course of presumptive COVID-19 and understand risk factors for poor outcomes study the usability of a virtual platform for managing a pandemic "We also hope to offer patients in Get Well Loop future confirmatory antibody testing so we can explore the accuracy of our clinical diagnosis and the utility of laboratory confirmation in the management of symptomatic populations," said Adam.